— Know what they know.
Not Investment Advice
Also trades as: 1093.HK (HKSE) · $vol 130M · CSPCY (OTC) · $vol 0M

CHJTF OTC

CSPC Pharmaceutical Group Limited
1W: +0.0% 1M: +0.0% 3M: +13.3% YTD: +16.8% 1Y: +2.8% 3Y: +53.5% 5Y: +3.7%
$1.11
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - General · Tech Score Neutral · Power 54 · $12.7B mcap · 7.63B float · 0.0000% daily turnover · Short 100% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
Oct 02, 2026
DCF
3
ROE
5
ROA
5
D/E
2
P/E
3
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CHJTF receives an overall rating of A-. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: D/E (2/5).
Rating Change History
DateFromTo
2026-10-01 A A-
2026-08-21 B+ A
2026-08-11 B B+
2026-07-25 B+ B
2026-07-22 None ADDED
2026-07-19 EXISTED None
2026-07-15 None ADDED
2026-07-11 EXISTED None
2026-07-07 None ADDED
2026-07-01 EXISTED None

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
98
Balance Sheet
94
Earnings Quality
50
Growth
57
Value
—
Momentum
84
Safety
—
Cash Flow
93

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
6/9
✓ ✓ ✓ ✓ ✗ ✗ ✓ ✓ ✗
Beneish M-Score
-3.28
Unlikely Manipulator
Ohlson O-Score
-12.37
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 82.8/100
Trend: Stable
Earnings Quality
75/100
OCF/NI: 1.89x
Accruals: -15.9%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CHJTF scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CHJTF's score of -3.28 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CHJTF's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CHJTF receives an estimated rating of AA- (score: 82.8/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CHJTF's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
13.04x
PEG
0.13x
P/S
3.13x
P/B
2.57x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$7.75
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 13.0x earnings, CHJTF trades at a reasonable valuation. Graham's intrinsic value formula yields $7.75 per share, suggesting a potential 598% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.795
NI / EBT
×
Interest Burden
0.884
EBT / EBIT
×
EBIT Margin
0.279
EBIT / Rev
×
Asset Turnover
0.910
Rev / Assets
×
Equity Multiplier
1.434
Assets / Equity
=
ROE
25.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CHJTF's ROE of 25.6% is driven by Asset Turnover (0.910), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
4.22%
Fair P/E
16.94x
Intrinsic Value
$13.74
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CHJTF's realized 4.2% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CHJTF trades at a premium to its adjusted intrinsic value of $13.74, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 16.9x compares to the current market P/E of 13.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1.11
Median 1Y
$0.89
5th Pctile
$0.31
95th Pctile
$2.56
Ann. Volatility
63.7%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
ROE 47.4% 51.3% 47.6% 52.9% 52.7% 55.3% 46.6% 48.3% 48.3% 50.2% 47.9% 46.3% 35.3% 25.5% 18.8% 24.0% 24.3% 19.5% 17.9% 25.6% 25.55%
ROA 31.8% 32.7% 32.7% 33.2% 34.8% 34.2% 32.9% 31.8% 34.1% 34.3% 34.9% 32.7% 25.7% 18.8% 13.7% 17.4% 17.5% 14.1% 12.8% 17.8% 17.82%
ROIC 41.9% 41.8% 47.5% 65.8% 74.1% 68.3% 53.8% 57.7% 56.5% 62.9% 53.8% 83.3% 63.7% 28.7% 18.2% 22.0% 22.2% 20.4% 25.5% 52.8% 52.82%
ROCE 52.8% 69.7% 59.4% 67.0% 63.7% 42.4% 41.7% 42.2% 40.1% 39.9% 41.2% 45.0% 36.5% 28.7% 21.2% 25.8% 27.1% 28.8% 24.4% 31.7% 31.68%
Gross Margin 52.6% 57.3% 63.2% 66.2% 68.6% 69.9% 74.1% 75.0% 74.9% 76.1% 75.5% 72.6% 71.2% 71.2% 2.5% 71.6% 68.2% 5.3% 65.6% 76.2% 76.15%
Operating Margin 21.5% 20.2% 21.9% 24.2% 21.6% 20.6% 20.0% 20.0% 24.5% 22.5% 22.3% 11.9% 10.5% 0.0% 23.6% 22.7% 13.8% 1.6% 11.0% 39.5% 39.51%
Net Margin 17.2% 18.2% 17.6% 19.3% 17.6% 16.8% 16.8% 18.4% 23.0% 22.2% 18.1% 9.7% 10.8% 19.2% 18.2% 18.5% 10.9% 19.2% 10.5% 32.8% 32.77%
EBITDA Margin 28.2% 54.7% 26.2% 54.9% 23.2% 23.0% 23.3% 23.2% 27.5% 25.6% 25.4% 15.3% 16.9% 23.8% 23.6% 26.8% 17.1% 1.9% 16.7% 43.1% 43.07%
FCF Margin 13.6% 13.3% 9.2% 8.4% 7.4% 5.1% 7.2% 8.0% 15.0% 18.0% 15.9% 18.6% 13.6% 11.7% 15.9% 9.8% 5.2% 5.6% 5.1% 24.8% 24.78%
OCF Margin 19.1% 19.6% 15.6% 16.1% 19.3% 18.1% 19.8% 19.2% 22.8% 24.1% 22.2% 25.0% 22.2% 22.1% 28.1% 20.4% 20.3% 20.8% 17.6% 37.1% 37.10%
ROE 3Y Avg snapshot only 29.18%
ROE 5Y Avg snapshot only 33.60%
ROA 3Y Avg snapshot only 20.70%
ROIC 3Y Avg snapshot only 56.20%
ROIC Economic snapshot only 28.00%
Cash ROA snapshot only 31.30%
Cash ROIC snapshot only 88.60%
CROIC snapshot only 59.19%
NOPAT Margin snapshot only 22.11%
Pretax Margin snapshot only 24.65%
R&D / Revenue snapshot only 19.91%
SGA / Revenue snapshot only 26.48%
SBC / Revenue snapshot only 0.28%
Valuation
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 13.037
P/S Ratio — — — — — — — — — — — — — — — — — — — — 3.132
P/B Ratio — — — — — — — — — — — — — — — — — — — — 2.568
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
PEG Ratio snapshot only 0.134
Graham Number snapshot only $7.75
Leverage & Solvency
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Current Ratio 2.06 1.95 2.37 1.59 1.90 2.12 2.20 2.09 2.53 2.76 2.30 2.70 2.36 2.50 2.63 2.54 2.27 2.24 2.19 2.14 2.139
Quick Ratio 1.64 1.44 1.86 1.28 1.54 1.72 1.79 1.81 2.23 2.50 2.02 2.39 2.11 2.22 2.32 2.20 1.95 1.95 1.88 1.93 1.934
Debt/Equity 0.13 0.11 0.08 0.07 0.00 0.02 0.01 0.01 0.01 0.01 0.00 0.03 0.02 0.01 0.02 0.01 0.02 0.01 0.02 0.02 0.017
Net Debt/Equity -0.19 -0.17 -0.35 -0.40 -0.44 -0.36 -0.30 -0.35 -0.38 -0.45 -0.33 -0.55 -0.53 -0.37 -0.37 -0.30 -0.24 -0.03 -0.25 -0.47 -0.474
Debt/Assets 0.09 0.07 0.05 0.04 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.02 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.012
Debt/EBITDA 0.16 0.13 0.11 0.07 0.01 0.02 0.02 0.03 0.03 0.01 0.01 0.05 0.05 0.04 0.08 0.04 0.05 0.04 0.06 0.04 0.041
Net Debt/EBITDA -0.24 -0.19 -0.48 -0.42 -0.48 -0.47 -0.47 -0.68 -0.78 -0.92 -0.68 -1.04 -1.17 -1.04 -1.42 -0.98 -0.73 -0.07 -0.74 -1.12 -1.117
Interest Coverage 58.95 102.15 150.42 123.45 157.02 108.75 123.85 226.49 221.29 484.64 602.68 548.79 372.11 308.17 206.16 319.55 614.26 861.54 505.23 402.38 402.379
Equity Multiplier 1.46 1.51 1.41 1.61 1.55 1.68 1.43 1.46 1.35 1.34 1.34 1.39 1.40 1.37 1.39 1.37 1.38 1.38 1.41 1.49 1.489
Cash Ratio snapshot only 1.282
Debt Service Coverage snapshot only 487.387
Cash to Debt snapshot only 28.334
FCF to Debt snapshot only 17.953
Defensive Interval snapshot only 354.0 days
Efficiency & Turnover
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Asset Turnover 1.92 1.93 1.86 1.82 1.92 1.93 1.88 1.83 1.80 1.69 1.71 1.80 1.67 1.35 1.05 1.08 1.08 0.90 0.92 0.91 0.910
Inventory Turnover 7.10 5.96 5.97 5.06 5.22 5.29 5.08 5.33 5.36 5.64 5.70 5.85 7.08 6.14 -0.01 0.06 0.17 -3.40 1.78 1.74 1.743
Receivables Turnover 11.58 32.30 17.55 17.63 13.19 15.88 18.10 15.80 11.46 9.61 14.98 9.77 9.97 9.27 6.77 7.13 7.27 7.15 4.56 6.89 6.891
Payables Turnover 9.81 7.69 9.63 3.18 5.17 6.32 9.81 3.47 5.27 7.52 9.93 8.29 9.31 7.92 -0.02 0.07 0.21 -4.11 1.90 1.89 1.886
DSO 32 11 21 21 28 23 20 23 32 38 24 37 37 39 54 51 50 51 80 53 53.0 days
DIO 51 61 61 72 70 69 72 69 68 65 64 62 52 59 — 6392 2146 — 205 209 209.3 days
DPO 37 47 38 115 71 58 37 105 69 49 37 44 39 46 — 5423 1745 — 192 194 193.5 days
Cash Conversion Cycle 46 25 44 -22 27 34 55 -14 31 54 52 56 49 53 — 1021 451 — 93 69 68.8 days
Fixed Asset Turnover snapshot only 3.466
Operating Cycle snapshot only 116.9 days
Cash Velocity snapshot only 2.557
Capital Intensity snapshot only 1.185
Growth (YoY)
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Revenue 18.4% 25.4% 33.3% 43.3% 57.2% 64.9% 63.5% 59.0% 52.2% 39.8% 38.4% 29.8% 22.0% -1.0% -24.0% -26.4% -28.2% -28.4% -3.4% 0.6% 0.59%
Net Income 74.2% 63.7% 63.1% 71.4% 72.5% 72.8% 62.9% 52.3% 57.9% 60.0% 61.2% 35.1% -0.9% -32.3% -51.4% -34.7% -24.3% -18.8% 2.7% 22.5% 22.47%
EPS 70.6% 60.1% 58.1% 64.9% 68.4% 68.9% 60.3% 52.7% 58.3% 60.1% 61.2% 35.6% -0.7% -32.0% -51.0% -34.2% -23.0% -15.5% 5.6% 27.0% 26.96%
FCF 2.5% 1.4% -2.6% -12.3% -14.9% -36.8% 28.9% 51.8% 2.1% 3.9% 2.0% 2.0% 10.3% -35.6% -24.1% -61.3% -72.7% -65.9% -69.2% 1.6% 1.56%
EBITDA 45.8% 21.9% 24.1% 93.0% 85.5% 47.8% 42.6% -11.9% -4.7% 12.8% 18.4% 30.9% 5.2% -20.8% -44.5% -28.8% -22.2% 8.0% 42.8% 50.4% 50.41%
Op. Income 49.8% 36.1% 37.0% 84.7% 84.8% 95.8% 81.3% 47.5% 47.3% 39.4% 44.4% 28.0% -2.8% -41.3% -61.6% -45.2% -32.0% 41.6% 87.5% 90.2% 90.19%
OCF Growth snapshot only 82.53%
Asset Growth snapshot only 17.02%
Equity Growth snapshot only 8.01%
Debt Growth snapshot only 67.79%
Shares Change snapshot only -3.54%
Dividend Growth snapshot only -20.83%
Growth (CAGR)
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Revenue 3Y 49.6% 36.8% 29.3% 41.3% 55.3% 58.4% 54.4% 49.2% 41.5% 42.5% 44.5% 43.5% 42.9% 31.7% 19.8% 15.0% 10.0% -0.3% 0.5% -1.3% -1.31%
Revenue 5Y — — — — — — — 71.5% 51.6% 42.6% 37.4% 42.3% 47.4% 40.7% 31.1% 26.0% 19.9% 15.4% 17.2% 17.0% 16.97%
EPS 3Y 13.1% 12.2% 59.6% 44.4% 34.2% 45.3% 42.0% 52.5% 65.7% 63.0% 59.9% 50.5% 38.3% 22.5% 8.2% 10.8% 6.6% -2.7% -5.9% 4.2% 4.22%
EPS 5Y — — — — — — — 44.9% 31.0% 30.7% 60.0% 44.2% 30.6% 27.3% 17.7% 25.9% 28.3% 20.0% 16.2% 23.3% 23.29%
Net Income 3Y 79.1% 77.8% 79.4% 60.0% 48.7% 48.2% 44.5% 54.7% 68.0% 65.4% 62.4% 52.2% 39.3% 23.2% 8.4% 10.4% 5.8% -4.2% -7.0% 2.6% 2.64%
Net Income 5Y — — — — — — — 91.8% 73.3% 73.1% 72.2% 53.2% 38.8% 28.6% 18.7% 26.7% 28.9% 20.0% 16.4% 23.1% 23.07%
EBITDA 3Y 65.8% 62.2% 57.3% 67.8% 59.6% 50.2% 46.6% 28.4% 37.1% 26.7% 28.0% 30.5% 23.0% 9.7% -2.1% -6.4% -8.0% -1.2% -2.1% 11.9% 11.90%
EBITDA 5Y — — — — — — — 76.1% 51.8% 48.1% 45.7% 40.4% 32.4% 24.8% 15.7% 14.5% 16.1% 11.7% 10.7% 19.0% 18.95%
Gross Profit 3Y 78.0% 71.8% 70.1% 86.3% 1.0% 1.0% 94.0% 89.4% 80.3% 77.6% 75.0% 69.4% 63.7% 47.2% 44.8% 35.7% 27.0% 22.1% 8.1% 5.5% 5.53%
Gross Profit 5Y — — — — — — — 1.1% 82.3% 75.8% 71.4% 75.2% 78.4% 65.8% 61.5% 55.1% 47.2% 45.6% 35.3% 33.5% 33.52%
Op. Income 3Y 69.4% 65.3% 65.7% 59.8% 51.9% 51.6% 47.0% 52.3% 59.8% 54.9% 53.1% 51.7% 38.3% 17.0% 0.2% 1.2% -0.9% 5.0% 1.3% 10.1% 10.10%
Op. Income 5Y — — — — — — — 88.1% 67.6% 65.3% 64.1% 50.4% 38.1% 23.3% 12.0% 19.9% 21.9% 25.3% 20.9% 29.5% 29.46%
FCF 3Y 1.4% 6.1% — — — 1.8% 1.1% 85.2% 1.1% 94.7% 56.2% 59.0% 42.8% 26.1% 43.7% 21.1% -2.3% 2.7% -10.9% 44.0% 44.04%
FCF 5Y — — — — — — — 1.0% 1.0% 3.1% — — — 1.3% 85.3% 49.3% 22.8% 10.1% -2.3% 31.8% 31.81%
OCF 3Y 70.3% 68.7% 54.5% 75.6% 1.1% 91.2% 93.5% 67.2% 66.6% 69.4% 50.1% 54.3% 50.2% 37.2% 45.9% 24.5% 11.8% 4.4% -3.4% 22.8% 22.82%
OCF 5Y — — — — — — — 85.7% 69.8% 68.6% 64.2% 77.0% 83.5% 63.9% 61.0% 36.5% 29.2% 24.4% 14.4% 32.1% 32.14%
Assets 3Y 1.1% 19.3% 1.1% 37.8% 28.7% 39.8% 46.2% 48.5% 53.1% 53.3% 55.6% 47.8% 46.8% 44.4% 37.0% 29.9% 24.1% 18.5% 20.9% 20.6% 20.58%
Assets 5Y — — — — — — — 31.9% 88.8% 35.8% 85.2% 36.0% 30.9% 34.0% 37.5% 37.5% 34.9% 33.2% 35.8% 36.0% 36.00%
Equity 3Y 1.5% 26.0% 1.6% 42.9% 41.5% 44.8% 52.5% 54.3% 60.0% 64.1% 63.2% 54.2% 48.7% 49.0% 37.4% 36.8% 29.0% 26.4% 21.4% 19.8% 19.81%
Book Value 3Y 59.6% -20.5% 1.3% 28.9% 27.7% 42.0% 49.9% 52.1% 57.8% 61.7% 60.7% 52.5% 47.7% 48.2% 37.1% 37.4% 29.9% 28.3% 22.9% 21.7% 21.66%
Dividend 3Y -15.0% -29.1% 5.8% -14.1% -15.1% 18.8% 9.1% 7.3% 33.6% 11.6% 26.4% 51.7% 14.8% 17.2% 11.5% 4.6% 12.8% 3.5% 4.6% -7.2% -7.18%
Growth Quality
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Revenue Stability 0.95 0.92 0.88 0.97 0.96 0.95 0.95 0.93 0.91 0.90 0.88 0.93 0.96 0.95 0.78 0.73 0.66 0.47 0.44 0.39 0.393
Earnings Stability 0.93 0.95 0.95 0.96 0.90 0.91 0.93 0.93 0.89 0.89 0.90 0.95 0.92 0.74 0.51 0.70 0.67 0.34 0.17 0.51 0.510
Margin Stability 0.73 0.70 0.66 0.65 0.64 0.67 0.70 0.63 0.63 0.62 0.62 0.64 0.67 0.70 0.65 0.66 0.67 0.60 0.71 0.73 0.733
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.500
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.86 1.00 0.87 0.50 0.86 0.90 0.92 0.99 0.91 0.910
Earnings Smoothness 0.46 0.52 0.52 0.47 0.47 0.47 0.52 0.59 0.55 0.54 0.53 0.70 0.99 0.61 0.31 0.58 0.72 0.79 0.97 0.80 0.798
ROE Trend 0.06 0.04 -0.05 0.00 0.06 0.03 -0.01 -0.03 -0.04 -0.04 0.02 0.01 -0.07 -0.17 -0.20 -0.18 -0.12 -0.13 -0.12 -0.07 -0.069
Gross Margin Trend 0.17 0.17 0.18 0.20 0.22 0.22 0.20 0.19 0.17 0.15 0.12 0.08 0.05 0.02 0.27 0.26 0.25 0.50 -0.01 0.01 0.010
FCF Margin Trend 0.12 0.09 0.01 -0.01 -0.02 -0.05 -0.04 -0.03 0.05 0.09 0.08 0.10 0.02 0.00 0.04 -0.04 -0.09 -0.09 -0.11 0.11 0.106
Sustainable Growth Rate 29.5% 37.7% 34.5% 42.8% 43.1% 40.2% 35.9% 40.5% 34.4% 37.8% 33.4% 26.4% 19.5% 10.2% 2.5% 6.1% 4.1% 4.2% 1.2% 13.7% 13.68%
Internal Growth Rate 24.6% 31.7% 31.1% 36.7% 39.8% 33.1% 33.9% 36.4% 32.0% 34.8% 32.2% 22.8% 16.5% 8.1% 1.8% 4.6% 3.0% 3.2% 0.9% 10.5% 10.54%
Cash Flow Quality
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
OCF/Net Income 1.15 1.16 0.89 0.89 1.06 1.02 1.13 1.11 1.21 1.19 1.09 1.38 1.45 1.59 2.16 1.27 1.25 1.32 1.27 1.89 1.894
FCF/OCF 0.71 0.68 0.59 0.52 0.38 0.28 0.37 0.41 0.66 0.75 0.71 0.74 0.61 0.53 0.56 0.48 0.25 0.27 0.29 0.67 0.668
FCF/Net Income snapshot only 1.265
OCF/EBITDA snapshot only 1.098
CapEx/Revenue 6.6% 6.6% 6.8% 7.7% 7.7% 9.1% 8.9% 8.2% 7.8% 6.1% 6.4% 5.9% 7.4% 9.0% 9.9% 9.1% 4.2% 2.6% 2.1% 2.3% 2.30%
CapEx/Depreciation snapshot only 0.390
Accruals Ratio -0.05 -0.05 0.04 0.04 -0.02 -0.01 -0.04 -0.03 -0.07 -0.06 -0.03 -0.12 -0.11 -0.11 -0.16 -0.05 -0.04 -0.05 -0.03 -0.16 -0.159
Sloan Accruals snapshot only -0.046
Cash Flow Adequacy snapshot only 3.253
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 2.92%
Dividend/Share $0.12 $0.09 $0.11 $0.09 $0.10 $0.16 $0.15 $0.12 $0.24 $0.24 $0.32 $0.42 $0.37 $0.39 $0.45 $0.48 $0.53 $0.43 $0.51 $0.38 $0.25
Payout Ratio 37.9% 26.5% 27.4% 19.1% 18.3% 27.3% 23.0% 16.1% 28.8% 24.8% 30.2% 43.1% 44.9% 60.0% 86.8% 74.5% 83.3% 78.4% 93.1% 46.5% 46.48%
FCF Payout Ratio 46.2% 33.6% 52.4% 41.5% 45.3% 94.7% 55.6% 35.3% 36.3% 27.9% 38.8% 42.1% 50.7% 71.1% 71.4% 1.2% 2.6% 2.2% 2.6% 36.7% 36.74%
Total Payout Ratio 37.9% 26.5% 27.9% 20.2% 20.8% 31.1% 26.2% 18.6% 29.9% 24.8% 32.7% 46.0% 48.2% 67.2% 94.8% 85.8% 89.9% 87.4% 1.0% 50.5% 50.53%
Div. Increase Streak 1 1 1 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 0 0
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Tax Burden (NI/EBT) 1.07 1.09 1.05 0.92 0.83 0.81 0.81 0.81 0.80 0.81 0.80 0.81 0.71 0.67 0.65 0.67 0.78 0.78 0.78 0.79 0.795
Interest Burden (EBT/EBIT) 0.71 0.54 0.58 0.69 0.80 1.01 1.03 1.08 1.11 1.15 1.13 1.10 1.22 1.19 1.24 1.17 1.02 0.79 0.81 0.88 0.884
EBIT Margin 0.22 0.29 0.29 0.29 0.27 0.22 0.21 0.20 0.21 0.22 0.22 0.20 0.18 0.17 0.16 0.21 0.20 0.26 0.22 0.28 0.279
Asset Turnover 1.92 1.93 1.86 1.82 1.92 1.93 1.88 1.83 1.80 1.69 1.71 1.80 1.67 1.35 1.05 1.08 1.08 0.90 0.92 0.91 0.910
Equity Multiplier 1.49 1.57 1.46 1.59 1.51 1.62 1.42 1.52 1.42 1.46 1.37 1.42 1.38 1.36 1.37 1.38 1.39 1.38 1.40 1.43 1.434
Per Share
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
EPS (Diluted TTM) $0.31 $0.36 $0.41 $0.47 $0.53 $0.60 $0.65 $0.72 $0.84 $0.96 $1.05 $0.97 $0.83 $0.66 $0.51 $0.64 $0.64 $0.55 $0.54 $0.81 $0.81
Book Value/Share $0.77 $0.82 $1.09 $1.14 $1.25 $1.38 $1.73 $1.83 $2.21 $2.46 $2.66 $2.35 $2.49 $2.67 $2.80 $2.94 $2.75 $2.91 $3.21 $3.29 $3.46
Tangible Book/Share $0.76 $0.80 $1.07 $1.06 $1.17 $1.24 $1.59 $1.76 $2.13 $2.39 $2.58 $2.19 $2.32 $2.46 $2.60 $2.73 $2.51 $2.66 $2.92 $3.01 $3.01
Revenue/Share $1.90 $2.11 $2.31 $2.58 $2.91 $3.39 $3.72 $4.11 $4.44 $4.75 $5.15 $5.35 $5.43 $4.72 $3.95 $3.97 $3.96 $3.52 $3.92 $4.14 $2.71
FCF/Share $0.26 $0.28 $0.21 $0.22 $0.21 $0.17 $0.27 $0.33 $0.67 $0.86 $0.82 $0.99 $0.74 $0.55 $0.63 $0.39 $0.20 $0.20 $0.20 $1.03 $1.07
OCF/Share $0.36 $0.41 $0.36 $0.42 $0.56 $0.61 $0.74 $0.79 $1.01 $1.14 $1.15 $1.34 $1.20 $1.04 $1.11 $0.81 $0.80 $0.73 $0.69 $1.54 $1.21
Cash/Share $0.25 $0.23 $0.47 $0.53 $0.55 $0.51 $0.54 $0.68 $0.88 $1.11 $0.90 $1.37 $1.38 $1.02 $1.10 $0.91 $0.70 $0.12 $0.86 $1.62 $1.62
EBITDA/Share $0.62 $0.73 $0.79 $1.08 $1.13 $1.05 $1.11 $0.95 $1.08 $1.19 $1.31 $1.25 $1.14 $0.94 $0.73 $0.90 $0.90 $1.06 $1.08 $1.40 $1.40
Debt/Share $0.10 $0.09 $0.08 $0.08 $0.01 $0.02 $0.02 $0.03 $0.03 $0.02 $0.01 $0.07 $0.05 $0.03 $0.06 $0.03 $0.04 $0.04 $0.06 $0.06 $0.06
Net Debt/Share $-0.15 $-0.14 $-0.38 $-0.45 $-0.55 $-0.49 $-0.52 $-0.65 $-0.85 $-1.10 $-0.89 $-1.31 $-1.33 $-0.98 $-1.04 $-0.88 $-0.66 $-0.08 $-0.80 $-1.56 $-1.56
Academic Models
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 8 7 7 6 7 8 7 9 8 9 9 7 5 4 6 5 5 5 5 6 6
Beneish M-Score -3.88 -3.03 -1.59 -3.48 -3.06 -0.93 1236.72 -1.81 3.60 -2.28 -1.77 -3.10 -2.70 -1.69 -2.07 -0.93 -2.11 -0.51 -0.68 -3.28 -3.278
Ohlson O-Score snapshot only -12.369
ROIC (Greenblatt) snapshot only 43.83%
Net-Net WC snapshot only $1.25
EVA snapshot only $8473629138.76
Credit
Metric Trend Q4'16 Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Credit Rating snapshot only AA-
Credit Score 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.750
Credit Grade snapshot only 4
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 100.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms